Biography

    Dr. Ulcickas Yood has more than 20 years professional experience in Epidemiologic research. Her research focuses on pharmacoepidemiology and drug safety as well as on methodologic issues relating to exposure measurement and data quality in large administrative databases. She collaborates with the Cancer Research Network to study cancer treatment effectiveness and sequelae.

    Dr. Ulcickas Yood has served on various advisory boards related to pharmacoepidemiology and drug safety and is currently a member of the Editorial Board for Pharmacoepidemiology and Drug Safety. She has published over 75 articles in numerous journals and is currently a co-investigator on 6 NIH funded grants. Dr. Ulcickas Yood is Principal Epidemiologist of EpiSource, LLC which is dedicated to the design and conduct of Pharmacoepidemiology studies and provides expert consultation to organizations.  She maintains an appointment as Senior Epidemiologist at the Josephine Ford Cancer Center, Henry Ford Hospital in Detroit.

Publications
    1. Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 5; 104(17):1293-305.
      View in: PubMed
     
    2. Kaufman PA, Brufsky AM, Mayer M, Rugo HS, Tripathy D, Yood MU, Feng S, Wang LI, Quah CS, Yardley DA. Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study. Breast Cancer Res Treat. 2012 Oct; 135(3):875-83.
      View in: PubMed
     
    3. Yood MU, Wells KE, Alford SH, Dakki H, Beiderbeck AB, Hurria A, Gross CP, Oliveria SA. Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy. Pharmacoepidemiol Drug Saf. 2012 Aug; 21(8):818-27.
      View in: PubMed
     
    4. Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):673-80.
      View in: PubMed
     
    5. Yood MU, Oliveria SA, Cziraky M, Hirji I, Hamdan M, Davis C. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin. 2012 Jan 9.
      View in: PubMed
     
    6. Ulcickas Yood M, Delorenze GN, Quesenberry CP, Oliveria SA, Tsai AL, Kim E, Cziraky MJ, McQuade RD, Newcomer JW, L'italien GJ. Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose? BMC Psychiatry. 2011 Dec 15; 11(1):197.
      View in: PubMed
     
    7. Field TS, Bosco JL, Prout MN, Gold HT, Cutrona S, Pawloski PA, Ulcickas Yood M, Quinn VP, Thwin SS, Silliman RA. Age, Comorbidity, and Breast Cancer Severity: Impact on Receipt of Definitive Local Therapy and Rate of Recurrence among Older Women with Early-Stage Breast Cancer. J Am Coll Surg. 2011 Dec; 213(6):757-65.
      View in: PubMed
     
    8. Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP. Long-term Safety of Radiotherapy and Breast Cancer Laterality in Older Survivors. Cancer Epidemiol Biomarkers Prev. 2011 Oct; 20(10):2120-6.
      View in: PubMed
     
    9. Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, Yood MU, Yardley DA. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res. 2011 Jul 15; 17(14):4834-43.
      View in: PubMed
     
    10. Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Dublin S, Platt R. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):138-45.
      View in: PubMed
     
    11. Ulcickas Yood M, Delorenze G, Quesenberry CP, Tsai AL, Phillips S, Willey VJ, Niemcryk SJ, Wells K, Skovron ML, Cziraky MJ, Carson W, Oliveria SA. Epidemiologic study of aripiprazole use and the incidence of suicide events. Pharmacoepidemiol Drug Saf. 2010 Nov; 19(11):1124-30.
      View in: PubMed
     
    12. Mapel D, Schum M, Yood M, Brown J, Miller D, Davis K. Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators. Prim Care Respir J. 2010 Jun; 19(2):109-17.
      View in: PubMed
     
    13. Donato BM, Burns L, Willey V, Cohenuram M, Oliveria S, Yood MU. Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report. Clin Ther. 2010 Mar; 32(3):546-54.
      View in: PubMed
     
    14. Gold HT, Thwin SS, Buist DS, Field TS, Wei F, Yood MU, Lash TL, Quinn VP, Geiger AM, Silliman RA. Delayed radiotherapy for breast cancer patients in integrated delivery systems. Am J Manag Care. 2009 Nov; 15(11):785-9.
      View in: PubMed
     
    15. Kozloff M, Yood MU, Berlin J, Flynn PJ, Kabbinavar FF, Purdie DM, Ashby MA, Dong W, Sugrue MM, Grothey A. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. Oncologist. 2009 Sep; 14(9):862-70.
      View in: PubMed
     
    16. Yood MU, DeLorenze G, Quesenberry CP, Oliveria SA, Tsai AL, Willey VJ, McQuade R, Newcomer J, L'Italien G. The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study. Pharmacoepidemiol Drug Saf. 2009 Sep; 18(9):791-9.
      View in: PubMed
     
    17. Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009 Sep 20; 27(27):4508-14.
      View in: PubMed
     
    18. Ahern TP, Bosco JL, Silliman RA, Yood MU, Field TS, Wei F, Lash TL. Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors. Clin Epidemiol. 2009; 1:93-100.
      View in: PubMed
     
    19. Lafata JE, Dobie EA, Divine GW, Ulcickas Yood ME, McCarthy BD. Sustained hyperglycemia among patients with diabetes: what matters when action is needed? Diabetes Care. 2009 Aug; 32(8):1447-52.
      View in: PubMed
     
    20. Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, Prout MN, Yood MU, Haque R, Wei F, Lash TL. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010 Jan; 63(1):64-74.
      View in: PubMed
     
    21. Tewari AK, Gold HT, Demers RY, Johnson CC, Yadav R, Wagner EH, Yood MU, Field TS, Divine G, Menon M. Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology. 2009 Mar; 73(3):624-30.
      View in: PubMed
     
    22. Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct; 17(10):1037.
      View in: PubMed
     
    23. Goff SL, Feld A, Andrade SE, Mahoney L, Beaton SJ, Boudreau DM, Davis RL, Goodman M, Hartsfield CL, Platt R, Roblin D, Smith D, Yood MU, Dodd K, Gurwitz JH. Administrative data used to identify patients with irritable bowel syndrome. J Clin Epidemiol. 2008 Jun; 61(6):617-21.
      View in: PubMed
     
    24. Owusu C, Buist DS, Field TS, Lash TL, Thwin SS, Geiger AM, Quinn VP, Frost F, Prout M, Yood MU, Wei F, Silliman RA. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2008 Feb 1; 26(4):549-55.
      View in: PubMed
     
    25. Oliveria SA, Menditto LA, Ulcickas Yood M, Koo YH, Wells KE, McCarthy BD. Barriers to the initiation of, and persistence with, insulin therapy. Curr Med Res Opin. 2007 Dec; 23(12):3105-12.
      View in: PubMed
     
    26. Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008 Feb; 23(2):158-63.
      View in: PubMed
     
    27. Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg. 2008 Jan; 206(1):66-75.
      View in: PubMed
     
    28. Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf. 2007 Oct; 16(10):1086-94.
      View in: PubMed
     
    29. Ulcickas Yood M, Quesenberry CP, Guo D, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Caldwell C, Manos MM. Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. J Viral Hepat. 2008 Jan; 15(1):28-36.
      View in: PubMed
     
    30. Yood MU, Campbell UB, Rothman KJ, Jick SS, Lang J, Wells KE, Jick H, Johnson CC. Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf. 2007 Sep; 16(9):961-8.
      View in: PubMed
     
    31. Buist DS, Ichikawa L, Prout MN, Yood MU, Field TS, Owusu C, Geiger AM, Quinn VP, Wei F, Silliman RA. Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care. J Clin Oncol. 2007 Aug 10; 25(23):3428-36.
      View in: PubMed
     
    32. Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1154-1159.e3.
      View in: PubMed
     
    33. Elston Lafata J, Simpkins J, Kaatz S, Horn JR, Raebel MA, Schultz L, Smith DH, Yood MU. What do medical records tell us about potentially harmful co-prescribing? Jt Comm J Qual Patient Saf. 2007 Jul; 33(7):395-400.
      View in: PubMed
     
    34. Ulcickas Yood M, Quesenberry CP, Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Manos MM. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology. 2007 Jul; 46(1):107-12.
      View in: PubMed
     
    35. Lash TL, Fox MP, Buist DS, Wei F, Field TS, Frost FJ, Geiger AM, Quinn VP, Yood MU, Silliman RA. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007 Jul 20; 25(21):3001-6.
      View in: PubMed
     
    36. Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. COPD. 2007 Jun; 4(2):127-34.
      View in: PubMed
     
    37. Lash TL, Fox MP, Thwin SS, Geiger AM, Buist DS, Wei F, Field TS, Yood MU, Frost FJ, Quinn VP, Prout MN, Silliman RA. Using probabilistic corrections to account for abstractor agreement in medical record reviews. Am J Epidemiol. 2007 Jun 15; 165(12):1454-61.
      View in: PubMed
     
    38. Geiger AM, Thwin SS, Lash TL, Buist DS, Prout MN, Wei F, Field TS, Ulcickas Yood M, Frost FJ, Enger SM, Silliman RA. Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer. 2007 Mar 1; 109(5):966-74.
      View in: PubMed
     
    39. Stang P, Morris L, Kempf J, Henderson S, Yood MU, Oliveria S. The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events. Am J Ther. 2007 Jan-Feb; 14(1):30-40.
      View in: PubMed
     
    40. Stang P, Frank C, Ulcickas Yood M, Wells K, Burch S. Impact of bipolar disorder: results from a screening study. Prim Care Companion J Clin Psychiatry. 2007; 9(1):42-7.
      View in: PubMed
     
    41. Yood MU, Watkins E, Wells K, Kucera G, Johnson CC. The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy. Pharmacoepidemiol Drug Saf. 2006 Dec; 15(12):852-60.
      View in: PubMed
     
    42. Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf. 2006 Dec; 15(12):861-72.
      View in: PubMed
     
    43. Yood MU, McCarthy BD, Kempf J, Kucera GP, Wells K, Oliveria S, Stang P. Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am Heart J. 2006 Oct; 152(4):777-84.
      View in: PubMed
     
    44. Enger SM, Thwin SS, Buist DS, Field T, Frost F, Geiger AM, Lash TL, Prout M, Yood MU, Wei F, Silliman RA. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006 Sep 20; 24(27):4377-83.
      View in: PubMed
     
    45. Yood MU, Lafata JE, Koro C, Wells KE, Pladevall M. Time to pharmacotherapy change in response to elevated HbA1c test results. Curr Med Res Opin. 2006 Aug; 22(8):1567-74.
      View in: PubMed
     
    46. Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf. 2006 Aug; 15(8):546-54.
      View in: PubMed
     
    47. Doubeni CA, Field TS, Ulcickas Yood M, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006 Jun 1; 106(11):2482-8.
      View in: PubMed
     
    48. Lafata JE, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Yood MU. Potential drug-drug interactions in the outpatient setting. Med Care. 2006 Jun; 44(6):534-41.
      View in: PubMed
     
    49. Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafata JE. Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care. 2006 Jun; 44(6):590-4.
      View in: PubMed
     
    50. Stang PE, Frank C, Kalsekar A, Yood MU, Wells K, Burch S. The clinical history and costs associated with delayed diagnosis of bipolar disorder. MedGenMed. 2006; 8(2):18.
      View in: PubMed
     
    51. Yood MU, Quesenberry CP, Alford SH, Tsai AL, Wells KE, Yood SM, Ackermann Shiff SP. An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications. Curr Med Res Opin. 2006 Feb; 22(2):307-14.
      View in: PubMed
     
    52. Stang P, Frank C, Yood MU, Wells K, Burch S, Muma B. Bipolar disorder detection, ascertainment, and treatment: primary care physician knowledge, attitudes, and awareness. Prim Care Companion J Clin Psychiatry. 2006; 8(3):147-52.
      View in: PubMed
     
    53. Puleo E, Zapka JG, Goins KV, Yood MU, Mouchawar J, Manos M, Somkin C, Taplin S. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof. 2005 Sep; 28(3):310-27.
      View in: PubMed
     
    54. Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, Lamerato L, Nathanson D, Cooper G. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005 Jun; 43(6):592-9.
      View in: PubMed
     
    55. Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005 May 4; 97(9):675-83.
      View in: PubMed
     
    56. Taplin SH, Barlow WE, Ulcickas-Yood M, Westbrook E, Geiger AM, Bischoff K, Ichikawa L. Re: Breast cancer screening comes full circle. J Natl Cancer Inst. 2005 Mar 16; 97(6):461.
      View in: PubMed
     
    57. Weinmann S, Taplin SH, Gilbert J, Beverly RK, Geiger AM, Yood MU, Mouchawar J, Manos MM, Zapka JG, Westbrook E, Barlow WE. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr. 2005; (35):33-8.
      View in: PubMed
     
    58. Mouchawar J, Taplin S, Ichikawa L, Barlow WE, Geiger AM, Weinmann S, Gilbert J, Manos MM, Ulcickas Yood M. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection? J Natl Cancer Inst Monogr. 2005; (35):39-46.
      View in: PubMed
     
    59. Zapka JG, Puleo E, Taplin S, Solberg LI, Mouchawar J, Somkin C, Geiger AM, Ulcickas Yood M. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts. J Natl Cancer Inst Monogr. 2005; (35):46-54.
      View in: PubMed
     
    60. Rolnick S, Hensley Alford S, Kucera GP, Fortman K, Ulcickas Yood M, Jankowski M, Johnson CC. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005; (35):96-101.
      View in: PubMed
     
    61. Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, Gilbert J, Mouchawar J, Leyden WA, Altaras R, Beverly RK, Casso D, Westbrook EO, Bischoff K, Zapka JG, Barlow WE. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst. 2004 Oct 20; 96(20):1518-27.
      View in: PubMed
     
    62. Oliveria SA, Yood MU, Campbell UB, Yood SM, Stang P. Treatment and referral patterns for colorectal cancer. Med Care. 2004 Sep; 42(9):901-6.
      View in: PubMed
     
    63. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004 Aug; 191(2):398-407.
      View in: PubMed
     
    64. Zapka JG, Puleo E, Taplin SH, Goins KV, Ulcickas Yood M, Mouchawar J, Somkin C, Manos MM. Processes of care in cervical and breast cancer screening and follow-up--the importance of communication. Prev Med. 2004 Jul; 39(1):81-90.
      View in: PubMed
     
    65. Goins KV, Zapka JG, Geiger AM, Solberg LI, Taplin S, Yood MU, Gilbert J, Mouchawar J, Somkin CP, Weinmann S. Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations. Am J Manag Care. 2003 Nov; 9(11):745-55.
      View in: PubMed
     
    66. Yood MU, Oliveria S, Boyer JG, Wells K, Stang P, Johnson CC. Colon polyp recurrence in a managed care population. Arch Intern Med. 2003 Feb 24; 163(4):422-6.
      View in: PubMed
     
    67. Delea TE, Vera-Llonch M, Edelsberg JS, McGarry L, Anton S, Ulcickas-Yood M, Oster G. The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health. 2002 Jan-Feb; 5(1):35-43.
      View in: PubMed
     
    68. Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, Soumerai S, Ross-Degnan D, Andrade S, Goodman MJ, Martinson B, Raebel MA, Smith D, Ulcickas-Yood M, Chan KA. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7.
      View in: PubMed
     
    69. Yood MU, Johnson CC, Blount A, Abrams J, Wolman E, McCarthy BD, Raju U, Nathanson DS, Worsham M, Wolman SR. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst. 1999 Sep 1; 91(17):1487-91.
      View in: PubMed
     
    70. Ulcickas Yood M, McCarthy BD, Lee NC, Jacobsen G, Johnson CC. Patterns and characteristics of repeat mammography among women 50 years and older. Cancer Epidemiol Biomarkers Prev. 1999 Jul; 8(7):595-9.
      View in: PubMed
     
    71. Velanovich V, Yood MU, Bawle U, Nathanson SD, Strand VF, Talpos GB, Szymanski W, Lewis FR. Racial differences in the presentation and surgical management of breast cancer. Surgery. 1999 Apr; 125(4):375-9.
      View in: PubMed
     
    72. Baker AM, McCarthy B, Gurley VF, Yood MU. Influenza immunization in a managed care organization. J Gen Intern Med. 1998 Jul; 13(7):469-75.
      View in: PubMed
     
    73. McCarthy BD, Yood MU, Bolton MB, Boohaker EA, MacWilliam CH, Young MJ. Redesigning primary care processes to improve the offering of mammography. The use of clinic protocols by nonphysicians. J Gen Intern Med. 1997 Jun; 12(6):357-63.
      View in: PubMed
     
    74. MacWilliam CH, Yood MU, Verner JJ, McCarthy BD, Ward RE. Patient-related risk factors that predict poor outcome after total hip replacement. Health Serv Res. 1996 Dec; 31(5):623-38.
      View in: PubMed
     
    75. McCarthy BD, Yood MU, Boohaker EA, Ward RE, Rebner M, Johnson CC. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996 Jul-Aug; 12(4):282-8.
      View in: PubMed
     
    76. McCarthy BD, Yood MU, Janz NK, Boohaker EA, Ward RE, Johnson CC. Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities. Cancer. 1996 May 15; 77(10):2070-6.
      View in: PubMed
     
    77. McCarthy BD, Yood MU, MacWilliam CH, Lee MJ. Screening mammography use: the importance of a population perspective. Am J Prev Med. 1996 Mar-Apr; 12(2):91-5.
      View in: PubMed
     
    78. Copeland M, Senkowski C, Ulcickas M, Mendelson M, Griepp RB. Breast size as a risk factor for sternal wound complications following cardiac surgery. Arch Surg. 1994 Jul; 129(7):757-9.
      View in: PubMed
     
    79. Berman IR, Ulcickas M, Yood SM, Grant RL. Cancer trends unique to Georgia. J Med Assoc Ga. 1993 Jan; 82(1):29-33.
      View in: PubMed
     
    80. Milunsky A, Morris JS, Jick H, Rothman KJ, Ulcickas M, Jick SS, Shoukimas P, Willett W. Maternal zinc and fetal neural tube defects. Teratology. 1992 Oct; 46(4):341-8.
      View in: PubMed
     
    81. Milunsky A, Ulcickas M, Rothman KJ, Willett W, Jick SS, Jick H. Maternal heat exposure and neural tube defects. JAMA. 1992 Aug 19; 268(7):882-5.
      View in: PubMed
     
    82. Jick H, Ulcickas M, Dean A. Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone. Pharmacotherapy. 1992; 12(6):451-4.
      View in: PubMed
     
    83. Richard BW, Ulcickas M, Lasagna L. Approvable letters in the FDA new drug approval process. J Clin Pharmacol. 1989 Aug; 29(8):680-4.
      View in: PubMed
     
    84. Tripathy D, Kaufman PA, Brufsky AM, Mayer M, Yood MU, Yoo B, Quah C, Yardley D, Rugo HS. First-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer From registHER. Oncologist. 2013; 18(5):501-10.
      View in: PubMed